PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q1 2019
Top Holdings136 positions
| 11.7M | $1.1B | 13.9% | — | — | — | First report — | |
| 3.7M | $1B | 13.2% | — | — | — | First report — | |
CELGENE CORP | 9.8M | $923.1M | 11.6% | — | — | 1 qtr | First report 0 |
| 5M | $557.4M | 7.0% | — | — | — | First report — | |
RED HAT INC | 1.8M | $322.5M | 4.1% | — | — | 1 qtr | First report 0 |
TURQUOISE HILL RESOURCES LTD | 187.9M | $311.9M | 3.9% | — | — | 1 qtr | First report 0 |
| 6.3M | $298.9M | 3.8% | — | — | — | First report — | |
WELLCARE HEALTH PLANS INC | 1.1M | $290M | 3.7% | — | — | 1 qtr | First report 0 |
| 1.4M | $221.9M | 2.8% | — | — | — | First report — | |
NXP SEMICONDUCTORS N V | 2.4M | $214.1M | 2.7% | $79.22 | 0.00% | 1 qtr | First report 0 |
DISNEY WALT CO | 1.8M | $195.8M | 2.5% | $107.17 | 0.00% | 1 qtr | First report 0 |
MELLANOX TECHNOLOGIES LTD | 1.6M | $185.8M | 2.3% | — | — | 1 qtr | First report 0 |
| 2M | $172.8M | 2.2% | — | — | — | First report — | |
| 3.6M | $133.6M | 1.7% | — | — | — | First report — | |
ARRIS INTERNATIONAL PLC | 4.2M | $132.4M | 1.7% | — | — | 1 qtr | First report 0 |
| 2.7M | $130.2M | 1.6% | — | — | — | First report — | |
INTEGRATED DEVICE TECHNOLOGY INC | 2.6M | $128.8M | 1.6% | — | — | 1 qtr | First report 0 |
PG&E CORP | 5.7M | $102.2M | 1.3% | $17.60 | 0.00% | 1 qtr | First report 0 |
ESPERION THERAPEUTICS INC NE | 2.5M | $99.4M | 1.3% | $40.15 | 0.00% | 1 qtr | First report 0 |
USCF Gold Strategy Plus Income | 2M | $86.3M | 1.1% | — | — | 1 qtr | First report 0 |
Pentwater Capital Management LP manages $7.9B across 136 positions as of Q1 2019. Top holdings: CELGENE CORP puts (13.9%), SPDR S&P 500 ETF TR puts (13.2%), CELG (11.6%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 136 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $7.9B across 136 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR